Dechra Pharma H1 Profit Down; Now Sees FY23 Profit At Lower End Of Market View
(RTTNews) – Dechra Pharmaceuticals Plc. (DPH.L) reported Monday that its first-half profit before tax was 29.7 million pounds, down from 53.4 million pounds last year.
Trending
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
An industry focused on death faces an existential crisis
Top Wall Street analysts recommend these dividend stocks for stable income
Michael Burry’s next ‘Big Short’: An inside look at his analysis showing AI is a bubble
Top Wall Street analysts favor these 3 stocks for solid upside potential
Activist Ananym Capital sees upside if Baker Hughes spins off its oilfield services business
Does Berkshire’s big tech bet signal a new risk tolerance in Omaha?
Robinhood shares head for brutal weekly loss as bitcoin, AI stocks are hit hard
Muddy Waters Capital’s Carson Block makes rare long call in Canadian miner Snowline Gold
Joe Terranova on the quantitative approach to the JOET ETF that identifies winners like Palantir early